Showing results (1-10 of 710) with videos related to
Sort By:
Pageof 71
Clinical Nephrology|March 1, 2015
Current ESRD burden and its future trend in Beijing, ChinaLiangying Gan, Li ZuoEndocrine|October 2, 2022
Roxadustat improves renal osteodystrophy by dual regulation of bone remodelingLuyao Li, Afang Li, Liangying Gan, et al.Blood Purification|May 26, 2021
COVID-19 Prevention and Control in Dialysis Centers during the Pandemic: A Single-Center ExperienceLiangying Gan, Bing Yang, Yan Wang, et al.Journal of Orthopaedic Surgery and Research|May 21, 2022
Roxadustat promotes osteoblast differentiation and prevents estrogen deficiency-induced bone loss by stabilizing HIF-1α and activating the Wnt/β-catenin signaling pathwayLuyao Li, Afang Li, Li Zhu, et al.Journal of Clinical Medicine|February 25, 2023
The Effect of Metabolic Syndrome and Its Individual Components on Renal Function: A Meta-AnalysisXu Li, Qichen Liang, Junfeng Zhong, et al.Renal Failure|March 28, 2022
Efficacy and safety of expanded hemodialysis in hemodialysis patients: a meta-analysis and systematic reviewYuchao Zhao, Liangying Gan, Qingyu Niu, et al.Nephrology (Carlton, Vic.)|July 25, 2019
Different type and dosage of heparin were not associated with the progression of coronary artery calcification in haemodialysis patientsQingyu Niu, Shuo Yang, Liangying Gan, et al.BMC Nephrology|July 27, 2020
The effects of dialysis modalities on the progression of coronary artery calcification in dialysis patientsQingyu Niu, Huiping Zhao, Li Zuo, et al.Hemodialysis International. International Symposium on Home Hemodialysis|June 11, 2020
Effect of long-term use of unfractionated or low-molecular-weight heparin on bone mineral density in maintenance hemodialysis patientsShuo Yang, Qingyu Niu, Liangying Gan, et al.International Immunopharmacology|October 15, 2025
Pegmolesatide ameliorates indoxyl sulfate-induced cardiomyocyte hypertrophy through modulating the EPOR-CD131-dependent JAK2/STAT3 signaling pathwayXinyu Zhang, Sufang Li, Tingru Lin, et al.Pageof 71